• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半定量和定量方法在预测类风湿关节炎相关间质性肺疾病进展中的潜力。

The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.

作者信息

Temiz Karadag Duygu, Dogan Sevtap, Cakir Ozgur, Altıntas Yusuf, Yilmaz Seyma, Gökcen Neslihan, Yazici Ayten, Cefle Ayse

机构信息

Division of Rheumatology, Department of Internal Medicine, Kocaeli University Faculty of Medicine, İzmit, Kocaeli, 41380, Turkey.

Department of Radiology, Kocaeli University Faculty of Medicine, İzmit, Kocaeli, Turkey.

出版信息

Clin Rheumatol. 2025 Jun;44(6):2213-2223. doi: 10.1007/s10067-025-07443-7. Epub 2025 May 15.

DOI:10.1007/s10067-025-07443-7
PMID:40369252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141109/
Abstract

INTRODUCTION

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) presents with variable severity and progression, highlighting the need for effective tools to identify patients at risk. Although CT imaging plays a vital role in the management of RA-ILD, there is a lack of objective methods to predict disease progression. This study investigates the association between semi-quantitative and quantitative CT scoring methods and disease progression in early-stage RA-ILD.

METHODS

This observational study analyzed baseline and the first technically evaluable follow-up CT scans of patients who met the 2010 ACR/EULAR classification criteria for RA and were diagnosed with ILD. Only patients with ≤ 5 years between baseline and follow-up scans were included. Semi-quantitative assessments were conducted using the Goh and Warrick scoring systems, while quantitative analyses utilized Vitrea software to measure mean lung attenuation (MLA) and low-, medium-, and high-density lung volumes. Progression risk factors were evaluated using binary logistic regression, with progression defined by changes in CT parameters over time.

RESULTS

A total of 77 RA-ILD patients (45 females, 32 males) were included, with a median follow-up period of 20 months (interquartile range: 7.4-46 months). Disease progression was observed in 34 patients (44.2%). Baseline medium-density volume (MDV), follow-up mean lung attenuation (MLA), and low-density volume (LDV) differed significantly between the progression and non-progression groups (p < 0.05). Quantitative CT parameters demonstrated strong correlations with both the Goh and Warrick scoring systems. Binary logistic regression analysis identified the usual interstitial pneumonia (UIP) pattern on baseline imaging as the only independent predictor of disease progression (odds ratio: 3.1; 95% confidence interval: 1.1-12.4).

CONCLUSION

In this study of early-stage RA-ILD patients, only the usual interstitial pneumonia (UIP) pattern on baseline HRCT independently predicted disease progression. Neither semi-quantitative scores nor quantitative CT parameters were predictive of progression. However, quantitative CT metrics demonstrated strong correlations with traditional scoring systems, supporting their utility in objectively assessing disease extent.

摘要

引言

类风湿关节炎相关间质性肺疾病(RA-ILD)的严重程度和进展情况各不相同,这凸显了需要有效的工具来识别有风险的患者。尽管CT成像在RA-ILD的管理中起着至关重要的作用,但缺乏预测疾病进展的客观方法。本研究调查了半定量和定量CT评分方法与早期RA-ILD疾病进展之间的关联。

方法

这项观察性研究分析了符合2010年美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)类风湿关节炎分类标准且被诊断为ILD的患者的基线CT扫描和首次可进行技术评估的随访CT扫描。仅纳入基线扫描和随访扫描间隔≤5年的患者。使用Goh和Warrick评分系统进行半定量评估,而定量分析则利用Vitrea软件测量平均肺衰减(MLA)以及低、中、高密度肺容积。使用二元逻辑回归评估进展风险因素,进展定义为CT参数随时间的变化。

结果

共纳入77例RA-ILD患者(45例女性,32例男性),中位随访期为20个月(四分位间距:7.4 - 46个月)。34例患者(44.2%)出现疾病进展。进展组和非进展组之间的基线中密度容积(MDV)、随访平均肺衰减(MLA)和低密度容积(LDV)存在显著差异(p < 0.05)。定量CT参数与Goh和Warrick评分系统均显示出强相关性。二元逻辑回归分析确定基线成像上的普通型间质性肺炎(UIP)模式是疾病进展的唯一独立预测因素(比值比:3.1;95%置信区间:1.1 - 12.4)。

结论

在这项针对早期RA-ILD患者的研究中,仅基线高分辨率CT(HRCT)上的普通型间质性肺炎(UIP)模式可独立预测疾病进展。半定量评分和定量CT参数均不能预测疾病进展。然而,定量CT指标与传统评分系统显示出强相关性,支持其在客观评估疾病范围方面的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/99f036c7457c/10067_2025_7443_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/26925c6f43cc/10067_2025_7443_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/b0d83f8cfcec/10067_2025_7443_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/99f036c7457c/10067_2025_7443_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/26925c6f43cc/10067_2025_7443_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/b0d83f8cfcec/10067_2025_7443_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d66/12141109/99f036c7457c/10067_2025_7443_Fig3_HTML.jpg

相似文献

1
The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.半定量和定量方法在预测类风湿关节炎相关间质性肺疾病进展中的潜力。
Clin Rheumatol. 2025 Jun;44(6):2213-2223. doi: 10.1007/s10067-025-07443-7. Epub 2025 May 15.
2
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
3
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.阿巴西普治疗类风湿关节炎间质性肺疾病的疗效与安全性:一项系统文献综述
Autoimmun Rev. 2021 Jun;20(6):102830. doi: 10.1016/j.autrev.2021.102830. Epub 2021 Apr 19.
4
Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review.类风湿关节炎患者间质性肺疾病的影像学表现:文献复习。
Autoimmun Rev. 2018 Feb;17(2):87-93. doi: 10.1016/j.autrev.2017.09.013. Epub 2017 Nov 28.
5
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
6
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.预测系统性硬化症相关间质性肺病进展患者后续病情进展的风险:一项多中心观察性队列研究。
Lancet Rheumatol. 2025 Jul;7(7):e463-e471. doi: 10.1016/S2665-9913(25)00026-8. Epub 2025 May 14.
7
Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement.类风湿关节炎间质性肺疾病中的沃里克评分:评估肺部受累程度和进展的一种有前景的工具。
Adv Rheumatol. 2025 Jan 25;65(1):5. doi: 10.1186/s42358-025-00435-w.
8
Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study.在荷兰使用家庭监测检测系统性硬化症相关间质性肺病患者的肺功能下降(DecreaSSc):一项前瞻性观察研究。
Lancet Rheumatol. 2025 Mar;7(3):e178-e186. doi: 10.1016/S2665-9913(24)00236-4. Epub 2024 Nov 8.
9
Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.临床变量及肺部超声检查用于类风湿关节炎患者间质性肺疾病的筛查
Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510-z.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Targeting fibroblast activation protein in rheumatoid arthritis: from molecular imaging to precision therapeutics.靶向类风湿关节炎中的成纤维细胞活化蛋白:从分子成像到精准治疗
Front Immunol. 2025 Jun 18;16:1616618. doi: 10.3389/fimmu.2025.1616618. eCollection 2025.

本文引用的文献

1
Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease.类风湿关节炎相关间质性肺疾病的定量CT扫描分析
Chest. 2025 May;167(5):1428-1439. doi: 10.1016/j.chest.2024.10.052. Epub 2024 Nov 9.
2
A Systematic Review of the Key Predictors of Progression and Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease.类风湿关节炎相关间质性肺疾病进展和死亡率关键预测因素的系统评价
Diagnostics (Basel). 2024 Aug 28;14(17):1890. doi: 10.3390/diagnostics14171890.
3
Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis.
类风湿关节炎患者间质性肺疾病的临床病程
ACR Open Rheumatol. 2024 Dec;6(12):836-845. doi: 10.1002/acr2.11736. Epub 2024 Sep 7.
4
Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study.类风湿关节炎相关间质性肺疾病患者死亡的危险因素:一项单中心前瞻性队列研究。
Arthritis Res Ther. 2024 Jul 19;26(1):137. doi: 10.1186/s13075-024-03362-1.
5
Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关间质性肺疾病的筛查和诊断的最新进展。
Expert Rev Clin Immunol. 2023 Jun;19(6):613-626. doi: 10.1080/1744666X.2023.2198212. Epub 2023 Apr 10.
6
Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病的肺功能轨迹。
Rheumatology (Oxford). 2023 Sep 1;62(9):3014-3024. doi: 10.1093/rheumatology/kead027.
7
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
8
Automated quantification system predicts survival in rheumatoid arthritis-associated interstitial lung disease.自动化定量系统预测类风湿关节炎相关间质性肺病的生存情况。
Rheumatology (Oxford). 2022 Nov 28;61(12):4702-4710. doi: 10.1093/rheumatology/keac184.
9
Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort.临床和亚临床类风湿关节炎相关间质性肺病的发病率、危险因素和死亡率:一项基于人群的队列研究。
Arthritis Care Res (Hoboken). 2022 Dec;74(12):2042-2049. doi: 10.1002/acr.24856. Epub 2022 Aug 10.
10
The Extent and Diverse Trajectories of Longitudinal Changes in Rheumatoid Arthritis Interstitial Lung Diseases Using Quantitative HRCT Scores.使用定量高分辨率CT评分评估类风湿关节炎间质性肺疾病纵向变化的程度和多样轨迹。
J Clin Med. 2021 Aug 25;10(17):3812. doi: 10.3390/jcm10173812.